The Enterprise Value as of November 2024 (TTM) for Mirum Pharmaceuticals, Inc. (MIRM) is 2.01B

According to Mirum Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.01B. This represents a change of 43.83% compared to the average of 1.40B of the last 4 quarters.

Mirum Pharmaceuticals, Inc. (MIRM) Historical Enterprise Value (quarterly & annually)

How has MIRM Enterprise Value performed in the past?

The mean historical Enterprise Value of Mirum Pharmaceuticals, Inc. over the last ten years is 549.82M. The current 2.01B Enterprise Value has changed 36.51% with respect to the historical average. Over the past ten years (40 quarters), MIRM's Enterprise Value was at its highest in in the June 2024 quarter at 1.70B. The Enterprise Value was at its lowest in in the December 2018 quarter at -15957639.06.

Mirum Pharmaceuticals, Inc. (MIRM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mirum Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mirum Pharmaceuticals, Inc. (MIRM) Average Enterprise Value

How has MIRM Enterprise Value performed in the past?

The current Enterprise Value of Mirum Pharmaceuticals, Inc. (MIRM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Mirum Pharmaceuticals, Inc. (MIRM) Enterprise Value vs. Peers

How is MIRM’s Enterprise Value compared to its peers?

Mirum Pharmaceuticals, Inc.’s Enterprise Value is greater than Immunocore Holdings plc (1.53B), greater than Larimar Therapeutics, Inc. (453.31M), greater than KalVista Pharmaceuticals, Inc. (477.00M), greater than Lyra Therapeutics, Inc. (22.05M), greater than Terns Pharmaceuticals, Inc. (508.25M), greater than Amylyx Pharmaceuticals, Inc. (316.21M), greater than Acumen Pharmaceuticals, Inc. (137.49M), greater than Inozyme Pharma, Inc. (308.76M), greater than X4 Pharmaceuticals, Inc. (20.60M), greater than Day One Biopharmaceuticals, Inc. (1.07B), less than MoonLake Immunotherapeutics (2.58B), less than Apellis Pharmaceuticals, Inc. (3.59B), less than Blueprint Medicines Corporation (6.13B), less than Cerevel Therapeutics Holdings, Inc. (8.24B), greater than Arcutis Biotherapeutics, Inc. (1.14B), greater than Icosavax, Inc. (713.87M), greater than VectivBio Holding AG (848.58M),

Build a custom stock screener for Mirum Pharmaceuticals, Inc. (MIRM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mirum Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mirum Pharmaceuticals, Inc. (MIRM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mirum Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.